Masha Paule Nathalie Strømme
Director/Board Member at EXACT THERAPEUTICS
Net worth: 2 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jan-Eric Wilhelm Ahlfors | M | - |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | - |
| Anders Wold | M | - | 3 years | |
| Svein Kvåle | M | - | 12 years | |
| Terezia Prikrylova | F | - |
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | - |
| Zeno Albisser | M | - |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | - |
| Adam Brian Robertson | M | - |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | - |
| Per Walday | M | 64 | 2 years | |
| John Edminson | M | - | 2 years | |
| Alexander Lidmejer | M | 43 | 14 years | |
| Dallas Hack | M | 71 |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | - |
| Amir Snapir | M | - | 2 years | |
| Johan Caspar Foghsgaard | M | - | 1 years | |
| William Castell | M | 76 | 6 years | |
| Steven Powell | M | - |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | - |
| Sharath Reddy | M | - | 2 years | |
| Ragnar Bendiksen | M | 50 | - | |
| Madhavan Balachandran | M | 73 |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | 6 years |
| Dag Wilhelm Ringvold Strømme | M | 58 |
PAACS Invest AS
| - |
| Ann-Tove Kongsnes | F | 57 | - | |
| Lionel Tarassenko | M | 67 |
University of Oxford
| 27 years |
| Stephen Davies | M | 74 |
University of Oxford
| 28 years |
| Cecilie S. Sverdrup | F | - |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Per-Anders Elvertrø | M | 49 | 10 years | |
| Jason Evans | M | - |
University of Oxford
| 9 years |
| Olof Milveden | M | 70 | - | |
| Argyris Stasinakis | M | - |
University of Oxford
| 8 years |
| Byron Auguste | M | 56 |
University of Oxford
| 4 years |
| Rupert Charles de Borchgrave d'Altena | M | - |
University of Oxford
| 7 years |
| Per Christian Sontum | M | - | 8 years | |
| Truman Packard | M | - |
University of Oxford
| 7 years |
| Andrew John Healey | M | - | 8 years | |
| Nigel L. Clarke | M | - |
University of Oxford
| 4 years |
| Kathryn Farrar | F | 47 |
University of Oxford
| 5 years |
| Taksz Ildiko | M | 55 |
University of Oxford
| 5 years |
| Doron Junger | M | - |
University of Oxford
| 6 years |
| Peter A. Chew | M | - |
University of Oxford
| 5 years |
| Simon Wolfgang Hartmut Goeller | M | 44 |
University of Oxford
| 5 years |
| Siddharth T. Patel | M | 46 |
University of Oxford
| 6 years |
| Girindre Beeharry | M | - |
University of Oxford
| 2 years |
| Torbjörn Sannerstedt | M | 64 | - | |
| Tom Juhani Rönnlund | M | 51 | 3 years | |
| Julian Graeme Ross | M | 59 |
University of Oxford
| 6 years |
| Rayhan Davis | M | 45 |
University of Oxford
| 4 years |
| Mark Carney | M | 59 |
University of Oxford
| 3 years |
| William Ashby | M | - |
University of Oxford
| 4 years |
| Philip Shapiro | M | 49 |
University of Oxford
| 3 years |
| Soo Chuen Tan | M | - |
University of Oxford
| 3 years |
| Antony J. Fairbanks | M | - |
University of Oxford
| 3 years |
| Michael Drexler | M | - |
University of Oxford
| 4 years |
| Frank Lampen | M | - |
University of Oxford
| 3 years |
| Bruce Niven | M | - |
University of Oxford
| 4 years |
| Paul Frost | M | - |
University of Oxford
| 3 years |
| Jason Gardner | M | 53 |
University of Oxford
| 4 years |
| Georgina Wells | F | - |
University of Oxford
| 3 years |
| Julian Mitchell | M | - |
University of Oxford
| 3 years |
| Ian Alistair Jensen-Humphreys | M | - |
University of Oxford
| 4 years |
| Matthew O'Kane O Kane | M | - |
University of Oxford
| 3 years |
| Ben Kilmartin | M | - |
University of Oxford
| 4 years |
| Will Pearson | M | - |
University of Oxford
| 4 years |
| Robin Bell Jones | M | - |
University of Oxford
| 5 years |
| Martin Bavinton | M | - |
University of Oxford
| 4 years |
| Nicola Broughton | M | - |
University of Oxford
| - |
| Jun Li | M | 63 |
University of Oxford
| 3 years |
| Alan Jonathan Dodsworth | M | - |
University of Oxford
| 4 years |
| Nailesh Rambhai | M | - |
University of Oxford
| 3 years |
| John Lachlan Gray MacDougall | M | - |
University of Oxford
| 4 years |
| Lucia Gunn | F | - |
University of Oxford
| 3 years |
| Jim Whittington | M | - |
University of Oxford
| 3 years |
| Tom Reusch | M | - |
University of Oxford
| 3 years |
| Ken Hsia | M | - |
University of Oxford
| 3 years |
| Raj Dutta | M | - |
University of Oxford
| 3 years |
| Philipp Michael Hildebrand | M | 60 |
University of Oxford
| 3 years |
| Matt Ludbrook | M | - |
University of Oxford
| 4 years |
| Azeem Azhar | M | - |
University of Oxford
| 4 years |
| Patrick Keefe | M | - |
University of Oxford
| 2 years |
| Rebecca Gibson | F | - |
University of Oxford
| 3 years |
| Timothy Ashlin | M | 47 |
University of Oxford
| 3 years |
| Gregg Robins | M | - |
University of Oxford
| 5 years |
| Oliver James Bevan | M | 47 |
University of Oxford
| 3 years |
| Theresa Comiskey Olsen | F | 61 | 1 years | |
| Carolyn Anne Prowse | F | 52 |
University of Oxford
| 4 years |
| Carlos Elizondo Mayer-Serra | M | 62 |
University of Oxford
| 3 years |
| Phil Smeaton | M | - |
University of Oxford
| 3 years |
| Scott Weiner | M | - |
University of Oxford
| 6 years |
| Colin Jamie Brammer | M | - |
University of Oxford
| 3 years |
| Ian Gardiner | M | - |
University of Oxford
| 4 years |
| Thomas Casdagli | M | 47 |
University of Oxford
| 4 years |
| Jonathan Montagu | M | - |
University of Oxford
| 5 years |
| Christopher James Good | M | 45 |
University of Oxford
| 4 years |
| Harry Seekings | M | 51 |
University of Oxford
| 3 years |
| Thomas Wei | M | 48 |
University of Oxford
| 2 years |
| Eduardo Bruno Martins | M | 61 |
University of Oxford
| 3 years |
| Jamie Rivers | M | - |
University of Oxford
| 3 years |
| Philipp Alexander von Hagen | M | 54 |
University of Oxford
| 3 years |
| Francesca Jane McDonagh | F | 48 |
University of Oxford
| 4 years |
| Jim Maun | M | - |
University of Oxford
| 3 years |
| Mark Jennings | M | 63 |
University of Oxford
| 3 years |
| Houman Ashrafian | M | 49 |
University of Oxford
| 4 years |
| Paul Woodman | M | - |
University of Oxford
| 4 years |
| Madeline Cowley | F | - |
University of Oxford
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 73 | 73.00% |
| Norway | 25 | 25.00% |
| Canada | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Masha Paule Nathalie Strømme
- Personal Network
